In a rare tame week for key economic data it is Thursday’s job figures that clearly stands out.

We look at two stocks in the IIR Pharma & Biotech Index that were the best performers in the top 10, both increasing over 40% for the month on the back of promising developments for their respective products.

Is it time to buy the dips or are Tesla and tech stocks doomed?

These two Aussie companies are ‘oldies’ but are they ‘goodies’? When Jun Bei Liu was asked about Telstra (our 45-year-old telecommunications company) and AMP (our 171-year-old insurance house), here’s what she said…

The overlooked small cap champions defying the Coronavirus gloom.

Let’s look at CSL, Fisher & Paykel Healthcare, Cochlear, Resmed and Ansell.

While international travel isn’t on the cards for 2020, it’s never too early to start thinking about where to head next and how to get there without spending a fortune.

As the COVID-19 pandemic causes uncertainties across economies and capital markets globally, seasoned investors and investment bankers are looking to one sector that’s proven time and time again to hold its solid ground in times of crisis.

The new-found passion of working from home could have a sting in the tail — these workers might have to compete with overseas online labour that’s much cheaper.

Find out the cheapest home loan and credit card rates, the highest term deposit and the best super funds over five years.

EuroManganese Ltd. (ASX:EMN) is capturing investor attention by developing a waste recycling operation to extract high purity manganese products for the manufacture of lithium ion batteries.

Post Royal Commission they tried to be good but we wondered if they could, cause they’ve had more bad habits than anyone.